user

Clinical characteristics of headache after vaccination against COVID-19 (Coronavirus SARS-CoV-2) with the COVID-19 Vaccine AstraZeneca: a prospective multicentre observational cohort study

被引：0
|
作者：
Goebel, C. [1 ,2 ]
Heinze, A. [2 ]
Karstedt, S. [1 ,2 ]
Morscheck, M. [2 ]
Tashiro, L. [2 ]
Cirkel, A. [1 ,2 ]
Hamid, Q. [3 ]
Halwani, R. [3 ]
Temsah, M. H. [4 ]
Ziemann, M. [5 ]
Goerg, S. [5 ]
Muente, T. [1 ]
机构：
[1] Univ Hosp Schleswig Holstein, Dept Neurol, Lubeck, Germany
[2] Kiel Headache & Pain Ctr, Kiel, Germany
[3] Univ Sharjah, Coll Med, Sharjah, U Arab Emirates
[4] King Saud Univ, Coll Med, Riyadh, Saudi Arabia
[5] Univ Hosp Schleswig Holstein, Inst Transfus Med, Lubeck, Germany
来源：
CEPHALALGIA | 2021年 / 41卷 / 1_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P041
引用
收藏
页码：50 / 51
页数：2
相关论文
共 50 条
  • [1] Clinical characteristics of headache after vaccination against COVID-19 (Coronavirus SARS-CoV-2) with the COVID-19 Vaccine AstraZeneca: a prospective multicentre observational cohort study
    Goebel, C.
    Heinze, A.
    Karstedt, S.
    Morscheck, M.
    Tashiro, L.
    Cirkel, A.
    Hamid, Q.
    Halwani, R.
    Temsah, M. H.
    Ziemann, M.
    Goerg, S.
    Muente, T.
    JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1): : 33 - 34
  • [2] Clinical characteristics of headache after vaccination against COVID-19 (Coronavirus SARS-CoV-2) with the COVID-19 Vaccine BBIBP-CorV: a prospective multicentre observational cohort study
    Goebel, C.
    Heinze, A.
    Karstedt, S.
    Morscheck, M.
    Tashiro, L.
    Cirkel, A.
    Hamid, Q.
    Halwani, R.
    Temsah, M. H.
    Ziemann, M.
    Goerg, S.
    Muente, T.
    Goebel, H.
    CEPHALALGIA, 2021, 41 (1_SUPPL) : 113 - 113
  • [3] Clinical characteristics of headache after vaccination against COVID-19 (Coronavirus SARS-CoV-2) with the COVID-19 Vaccine BBIBP-CorV: a prospective multicentre observational cohort study
    Goebel, C.
    Heinze, A.
    Karstedt, S.
    Morscheck, M.
    Tashiro, L.
    Cirkel, A.
    Hamid, Q.
    Halwani, R.
    Temsah, M. H.
    Ziemann, M.
    Goerg, S.
    Muente, T.
    Goebel, H.
    JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1): : 76 - 76
  • [4] Clinical characteristics of headache after vaccination against COVID-19 (Coronavirus SARS-CoV-2) with the COVID-19 mRNA-1273 Moderna vaccine: a prospective multicentre observational cohort study
    Gobel, C.
    Heinze, A.
    Karstedt, S.
    Morscheck, M.
    Tashiro, L.
    Cirkel, A.
    Hamid, Q.
    Halwani, R.
    Temsah, M. H.
    Ziemann, M.
    Goerg, S.
    Munte, T.
    Goebel, H.
    JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1): : 54 - 54
  • [5] Clinical characteristics of headache after vaccination against COVID-19 (Coronavirus SARS-CoV-2) with the COVID-19 mRNA-1273 Moderna vaccine: a prospective multicentre observational cohort study
    Goebel, C.
    Heinze, A.
    Karstedt, S.
    Morscheck, M.
    Tashiro, L.
    Cirkel, A.
    Hamid, Q.
    Halwani, R.
    Temsah, M. H.
    Ziemann, M.
    Goerg, S.
    Muente, T.
    Goebel, H.
    CEPHALALGIA, 2021, 41 (1_SUPPL) : 81 - 82
  • [6] Clinical characteristics of headache after vaccination against COVID-19 (Coronavirus SARS-CoV-2) with the BNT162b2 mRNA vaccine: a prospective multicentre observational cohort study
    Goebel, C.
    Heinze, A.
    Karstedt, S.
    Morscheck, M.
    Tashiro, L.
    Cirkel, A.
    Hamid, Q.
    Halwani, R.
    Temsah, M. H.
    Ziemann, M.
    Goerg, S.
    Muente, T.
    Goebel, H.
    JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1): : 32 - 32
  • [7] Clinical characteristics of headache after vaccination against COVID-19 (Coronavirus SARS-CoV-2) with the BNT162b2 mRNA vaccine: a prospective multicentre observational cohort study
    Goebel, C.
    Heinze, A.
    Karstedt, S.
    Morscheck, M.
    Tashiro, L.
    Cirkel, A.
    Hamid, Q.
    Halwani, R.
    Temsah, M. H.
    Ziemann, M.
    Goerg, S.
    Muente, T.
    Goebel, H.
    CEPHALALGIA, 2021, 41 (1_SUPPL) : 48 - 48
  • [8] Clinical characteristics of headache after vaccination against COVID-19 (coronavirus SARS-CoV-2) with the BNT162b2 mRNA vaccine: a multicentre observational cohort study (vol 3, fcab169, 2021)
    Gobel, Carl H.
    Heinze, Axel
    Karstedt, Sarah
    Morscheck, Mascha
    Tashiro, Lilian
    Cirkel, Anna
    Hamid, Qutayba
    Halwani, Rabih
    Temsah, Mohamad-Hani
    Ziemann, Malte
    Gorg, Siegfried
    Munte, Thomas
    Gobel, Hartmut
    BRAIN COMMUNICATIONS, 2021, 3 (03)
  • [9] A Prospective Cohort Study of COVID-19 Vaccination, SARS-CoV-2 Infection, and Fertility
    Wesselink, Amelia K.
    Hatch, Elizabeth E.
    Rothman, Kenneth J.
    Wang, Tanran R.
    Willis, Mary D.
    Yland, Jennifer
    Crowe, Holly M.
    Geller, Ruth J.
    Willis, Sydney K.
    Perkins, Rebecca B.
    Regan, Annette K.
    Levinson, Jessica
    Mikkelsen, Ellen M.
    Wise, Lauren A.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2022, 191 (08) : 1383 - 1395
  • [10] Coronavirus, COVID-19 and SARS-CoV-2
    Megias, Jorge
    REVISTA HISPANOAMERICANA DE HERNIA, 2020, 8 (02) : 111 - 111
12345